GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RaQualia Pharma Inc (TSE:4579) » Definitions » E10

RaQualia Pharma (TSE:4579) E10 : 円-29.60 (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is RaQualia Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

RaQualia Pharma's adjusted earnings per share data for the three months ended in Jun. 2024 was 円-11.360. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円-29.60 for the trailing ten years ended in Jun. 2024.

During the past 3 years, the average E10 Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of RaQualia Pharma was 32.30% per year. The lowest was 32.30% per year. And the median was 32.30% per year.

As of today (2025-03-17), RaQualia Pharma's current stock price is 円396.00. RaQualia Pharma's E10 for the quarter that ended in Jun. 2024 was 円-29.60. RaQualia Pharma's Shiller PE Ratio of today is .


RaQualia Pharma E10 Historical Data

The historical data trend for RaQualia Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaQualia Pharma E10 Chart

RaQualia Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -76.99 -56.40 -31.04 -23.93

RaQualia Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.66 -20.26 -23.93 -32.41 -29.60

Competitive Comparison of RaQualia Pharma's E10

For the Biotechnology subindustry, RaQualia Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaQualia Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RaQualia Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where RaQualia Pharma's Shiller PE Ratio falls into.



RaQualia Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaQualia Pharma's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-11.36/108.2000*108.2000
=-11.360

Current CPI (Jun. 2024) = 108.2000.

RaQualia Pharma Quarterly Data

per share eps CPI Adj_EPS
201409 -31.430 98.500 -34.525
201412 -34.970 97.900 -38.649
201503 -27.780 97.900 -30.703
201506 -34.293 98.400 -37.708
201509 -36.380 98.500 -39.963
201512 -19.241 98.100 -21.222
201603 4.730 97.900 5.228
201606 -17.612 98.100 -19.425
201609 -16.360 98.000 -18.063
201612 -9.560 98.400 -10.512
201703 -3.440 98.100 -3.794
201706 -11.550 98.500 -12.687
201709 -9.170 98.800 -10.042
201712 19.978 99.400 21.747
201803 -15.330 99.200 -16.721
201806 -13.992 99.200 -15.261
201809 -12.151 99.900 -13.161
201812 -12.760 99.700 -13.848
201903 -5.050 99.700 -5.481
201906 -10.140 99.800 -10.993
201909 -10.750 100.100 -11.620
201912 25.641 100.500 27.606
202003 -15.660 100.300 -16.893
202006 -6.270 99.900 -6.791
202009 -11.420 99.900 -12.369
202012 4.375 99.300 4.767
202103 9.000 99.900 9.748
202106 5.450 99.500 5.927
202109 -6.380 100.100 -6.896
202112 27.970 100.100 30.233
202203 -5.770 101.100 -6.175
202206 28.150 101.800 29.920
202209 -0.120 103.100 -0.126
202212 12.200 104.100 12.680
202303 -6.880 104.400 -7.130
202306 8.043 105.200 8.272
202309 -6.630 106.200 -6.755
202312 -9.530 106.800 -9.655
202403 -3.610 107.200 -3.644
202406 -11.360 108.200 -11.360

Add all the adjusted EPS together and divide 10 will get our e10.


RaQualia Pharma  (TSE:4579) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


RaQualia Pharma E10 Related Terms

Thank you for viewing the detailed overview of RaQualia Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


RaQualia Pharma Business Description

Traded in Other Exchanges
N/A
Address
5-2 Taketoyo, Aichi, Taketoyo, JPN, 470-2341
RaQualia Pharma Inc is engaged in the research and development of pharmaceutical compounds.

RaQualia Pharma Headlines

No Headlines